Section Arrow
Quote
LMRI.NASDAQ
- Lumexa Imaging Holdings, Inc.
Quotes are at least 15-min delayed:2026/01/13 07:21 EST
Pre Market
Last
 --
-- (--)
Bid
15
Ask
20
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 15.82
-0.86 (-5.16%)
Day High 
17.23 
Prev. Close
16.68 
1-M High
19.45 
Volume 
702.11K 
Bid
15
Ask
20
Day Low
15.24 
Open
17 
1-M Low
15.81 
Market Cap 
1.58B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 17.64 
20-SMA 17.81 
50-SMA -- 
52-W High 19.45 
52-W Low 15.81 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.46/--
Enterprise Value
2.85B
Balance Sheet
Book Value Per Share
1.77
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
948.87M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OMOutset Medical Inc5.57+1.01+22.15%-- 
Pre Market 5.35 -0.22 -3.95%
ATECAlphatec Holdings17.59-5.06-22.34%-- 
Pre Market 17.7 +0.11 +0.63%
DXCMDexCom70.98+3.58+5.31%37.4PE
Pre Market 70.77 -0.21 -0.30%
PACBPacific Biosciences of California2.01+0.07+3.61%-- 
Pre Market 2.02 +0.01 +0.50%
MDTMedtronic plc96.95-0.58-0.59%26.55PE
Pre Market 97.2 +0.25 +0.26%
Industry overview quotes are at least 15 minutes delayed
Business Description
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties,mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.